Osteochondrosis is a condition involving defective endochondral ossification and retention of cartilage in subchondral bone. The pathophysiology of this condition is poorly characterized, but it has been proposed that the fundamental defect is failure of chondrocyte hypertrophy. The aim of the current study was to characterize phenotypic changes in chondrocytes associated with the initiation of osteochondrosis. Early lesions were induced in an equine model of osteochondrosis by feeding foals a high energy diet for 8 or 15 weeks. Lesions in articular-epiphyseal growth cartilage were examined histologically and by quantitative PCR analysis of expression of a number of genes representative of pathways that regulate chondrocyte behavior during endochondral ossification. There were more cells present in clusters in the lesions compared to normal articular cartilage. Expression of matrix metalloproteinase-13, type I collagen, type X collagen, and Runx2 mRNA was significantly greater in the lesions compared to normal cartilage from the same joint. Expression of vascular endothelial growth factor, type II collagen, connective tissue growth factor, aggrecan, Sox9, and fibroblast growth factor receptor 3 mRNA was not significantly different in lesions than in control cartilage. These observations suggest that osteochondrosis does not result from failure of chondrocytes to undergo hypertrophy. During the process of endochondral ossification, chondrocytes in growth cartilage undergo proliferation, followed by hypertrophy and physiological death. This orderly series of events is regulated by a number of secreted proteins, the actions of which are mediated by specific receptors, signaling cascades, and transcription factors. 1 Several factors are of particular interest. The high-mobility-group transcription factor Sox9 is the earliest known determinant of chondrocyte differentiation and cartilage formation, also regulating expression of the chondrocyte-specific extracellular matrix proteins type II collagen and aggrecan. 2 Fibroblast growth factor receptor 3 (FGFR3) has been shown to inhibit chondrocyte proliferation, with FGF18 possibly the important ligand in growth cartilage. 3,4 Endochondral ossification is blocked in Runx2-deficient mice, indicating an essential role for this transcription factor in chondrocyte differentiation. It has been shown that expression of Runx2 induces hypertrophy, alkaline phosphatase activity, and expression of type X collagen and matrix metalloproteinase-13 (MMP-13) 5 in chondrocytes, as well as mineralization of the cartilage matrix. In the later stages of endochondral ossification, Runx2 is involved in the vascular invasion of the cartilage, inducing the expression of the angiogenic factor, vascular endothelial growth factor (VEGF), which is necessary for vascular invasion, as well as the expression of VEGF receptors. 6 Evidence from a mouse model has shown that the collagen-degrading enzyme MMP-13 plays a role in invasion of the ossification front, with delayed endochondral ossif...